Loading organizations...
XT Venture Capital is an investment firm that provides capital, strategic advice, and operational support to early-stage technology companies. It focuses on identifying and nurturing future category leaders, guiding them from nascent stages to market leadership through active partnership and a broad network of connections. The firm leverages extensive experience to assist portfolio companies in navigating growth challenges and capitalizing on market opportunities.
XT Venture Capital, also known as XT Hi-Tech, was established in the late 1990s as the venture capital arm of the XT Group, which is chaired by Udi Angel, with Ori Angel serving as CEO of the larger group. The firm's inception was driven by an understanding that nascent companies require more than just capital, benefiting significantly from experienced guidance and robust infrastructure to navigate the complexities of scaling and market penetration.
The firm partners with ambitious founders and management teams across various technology sectors, aiming to transform innovative concepts into market-defining enterprises. XT Venture Capital’s long-term vision is to be a pivotal force in the global technology ecosystem, fostering the creation of enduring category leaders by building genuine partnerships and providing comprehensive support throughout their growth trajectory.
XT Investments has 1 tracked investment across 1 company. The latest tracked deal is $6.3M Series C in AngioSlide in January 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 3, 2013 | AngioSlide | $6.3M Series C | Michal Geva | Agate Medical Investments, Viola Partners |